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Molecular methods applied to 2,855 strains of
Campylobacter-like organisms received from a surveillance
network of Campylobacter infections in France identified 29
Arcobacter butzleri infections. This species ranks fourth for
Campylobacteraceae isolation and appears to have the
same pathogenic potential as the other species in the
genus.
K
iehlbauch et al. (1) originally described the species
Arcobacter butzleri, previously named
Campylobacter butzleri (1), after studying aerotolerant
Campylobacter strains from human and veterinary
sources. The genus Arcobacter was created in 1992 (2).
A. butzleri is found in environmental samples, and
untreated water appears to be a potential source of infec-
tion. In industrialized countries, the most important source
of human contamination may be food. Indeed, A. butzleri
has been isolated in different breeding animals and is pres-
ent in a great variety of retail meats, including chicken,
beef, pork, and lamb, with a high prevalence in poultry (3).
Although the prevalence of this bacterium in animals
and food specimens is well documented, including the first
publication by Kiehlbauch et al. that implied this newly
described species could be an important human pathogen,
only a few reports of human infections are found, and most
of them were published before 1995. In the Far East,
Taylor et al. formally identified A. butzleri in 2.4% of diar-
rheal stool samples collected from Thai children (4), and
more recently, 2 bacteremia cases were reported in Taiwan
and Hong Kong in patients with an underlying disease
(liver cirrhosis and gangrenous appendicitis, respectively)
(5,6). In a South African study, 15 A. butzleri were identi-
fied among 3,877 Campylobacteraceae strains isolated
from children’s diarrheic stools (7). Reports from Europe
are scarce: an outbreak of recurrent abdominal cramps in
10 patients in Italy (8), bacteremia in a newborn in the
United Kingdom (9), and 2 cases of severe diarrhea in
Germany (10). The recent publication of Vandenberg et al.
from Belgium used an Arcobacter-selective medium for
stool specimens and found that A. butzleri ranked fourth
among  Campylobacter spp. and Campylobacter-like
organisms (11), which stimulated interest to revisit the role
of Arcobacter spp. as an agent of enteric infection.
In this study, our goal was to investigate the prevalence
of A. butzleri with a different approach and to describe the
clinical features of A. butzleri infection. We used molecu-
lar methods to identify Campylobacter-related organisms
collected from a network of clinical laboratories that do
not use specific Arcobacter-selective medium. The results
nevertheless showed that this bacterium ranks fourth
among these organisms.
The Study
The French surveillance network of human
Campylobacter infections is composed of laboratories
selected on a voluntary basis (12). The laboratories are ran-
domly located throughout France; 93 are hospital laborato-
ries, and 338 are private laboratories. They send their
clinical Campylobacter isolates to the National Reference
Center with a completed information sheet concerning the
patient and epidemiologic data. The study period was from
July 2002 to December 2003, and 2,855 Campylobacter-
like strains were studied. In addition to standard phenotyp-
ic identification, specific polymerase chain reaction (PCR)
assays were carried out to identify C. jejuni, C. coli, or C.
fetus (13); other isolates were identified by comparing 2
sequences of 400 bp located at both extremities of a 1,100-
bp fragment of the beginning of the 16S rRNAgene ampli-
fied with primers F2-16S-CHPEC (ATCCTGGCTCAG-
AGTGAACG) and R2-16S-CHPEC (AAGGGCCATGAT-
GACTTGAC) with those of DNA databases by using the
BLAST program (http://www.ncbi.nlm.nih.gov/blast/). An
identification at the species level was regarded as correct
when >99% identity was seen with only 1 species. The
species distribution from stool samples was as follows:
2,114 C. jejuni (78.9%), 486 C. coli (18.1%), 36 C. fetus
(1.3%), 27 A. butzleri (1.0%), 8 C. lari (0.3%), 4 C.
upsaliensis (0.1%), 2 C. hyointestinalis, and 1
Helicobacter canadensis. From 177 nonstool samples, we
detected 2 A. butzleri. 
Almost the entire 16S rRNA gene, 1,450 bp, was
sequenced for 9 A. butzleri to study its homogeneity
because only 5 sequences are in the databank (accession
nos. AF314538, AY621116, L14626, U34386, U34388).
The intraspecies variability was only 0.4% (6/1,430 bp)
among the 14 A. butzleri sequences. Comparison of these
sequences with those of 4 A. cryaerophilus (AY314755,
L14624, U34387, U25805), 1 A. skirrowii (L14625), and 1
A. nitrofigilis (L14627) showed that interspecies variabili-
ty concerned 14 bp out of 1,430. The Arcobacter
sequences differed considerably from those of
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(AY621115) and 85.6% identity with C. fetus (AY621110),
2 species that can be phenotypically confounded with A.
butzleri.
Twenty-seven of the 29 A. butzleri strains were isolated
from feces of patients with gastroenteritis, whereas 1 strain
was isolated from peritonitis pus and another from a blood
culture specimen. The 27 Arcobacter strains from stools
were isolated in 23 different laboratories. Most of them (n
= 15) used Campylosel (bioMérieux, Marcy l’Etoile,
France) incubated at 37°C for 2 to 3 days. Six used
Karmali agar incubated at 37°C for 3 to 4 days. The last 2
used Butzler medium and the filtration method, respective-
ly. None of these infections was part of an outbreak. Of the
16 patients with travel information available, only 1 indi-
cated a recent trip, to Turkey. An associated pathogenic
organism was described in 1 of 15 cases, but the nature of
the associated organism is unknown. Seventeen of the 29
patients were hospitalized. Their age range was 1–89
years, with an average of 54 years. Seventeen patients
(59%) were male. Detailed clinical information was
obtained for 19 patients and is shown in the Table.
Eighteen of 19 patients had diarrhea, including the patient
with bacteremia; 11 of 15 had abdominal pain; 4 of 15 had
bloody stools, including the patient with A. butzleri bac-
teremia; 2 of 14 patients vomited; and 5 of 17 patients had
fever. Acute renal failure developed in 2 patients, 1 associ-
ated with pyelonephritis. Concerning the 17 other cases for
which information was available, severe clinical symp-
toms (anorexia, weight loss, asthenia) were described for
10 patients.
The duration of symptoms without treatment was vari-
able, from 2 days to several weeks. Antimicrobial drug
therapy was administered in 5 cases, and infection was
eradicated a few days later (Table). In all cases, the strains
were susceptible to the antimicrobial agent used (amoxi-
cillin, ofloxacin, ciprofloxacin [twice], amoxicillin-clavu-
lanate).
Conclusions
During an 18-month period, 2,855 strains of
Campylobacter-like organisms were identified at the
species level by using phenotypic and molecular tools.
Molecular methods permitted the identification of 29 A.
butzleri, i.e., 1% of the strains studied and also 1% of the
2,678 isolates from stools, which makes this species the
fourth most frequently isolated Campylobacteraceae in
human clinical samples in France, before C. lari and C.
upsaliensis but after C. jejuni, C. coli, and C. fetus. Our
results agree with those of Vandenberg et al. (11) who also
found A. butzleri in fourth position for Campylobacter-like
isolates from stool specimens. However, their results were
obtained in a different context: only 1 laboratory was
involved for 8 years, and a specific Arcobacter-selective
medium was used. A study conducted in Denmark by
Engberg et al. (14), also to estimate the prevalence of
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samples, did not produce the same results; only 1 A. butz-
leri was isolated out of 1,376 samples, and no C. lari or C.
upsaliensis was recovered. The differences between these
3 studies could be explained by differences in geographic
distribution of the species, but the difference in isolation
methods (selective agar in the Belgian study) or in identi-
fication methods (molecular methods in our study) is like-
ly the critical point. While not optimal, Campylobacter-
selective agars, especially Campylosel, appear to allow the
growth of A. butzleri. For the other media, a longer incu-
bation period seems necessary. The role of A. butzleri in
enteric infections is not definitively proven, but its
involvement is likely. In at least 14 of 15 cases, no other
enteropathogen was detected. In 1 case, a bacteremia with
an enteric infection was found. These data are similar to
those observed with C. jejuni infection. Isolation of A. but-
zleri is more frequent than well-known enteropathogenic
Campylobacter spp., e.g., C. upsaliensis and C. lari, when
adequate identification is carried out. The prevalence of A.
butzleri may be underestimated because of false identifica-
tion as C. coli or C. fetus. Indeed nearly all of the strains
are able to grow at 25°C, like C. fetus, but are resistant to
cephalothin like C. coli. We found that nearly all of the
strains were resistant to nalidixic acid (4 had an intermedi-
ary resistance) and susceptible to ciprofloxacin with the
disk diffusion method. The choice of a simple method for
testing these drugs allows it to be used routinely in clinical
laboratories to differentiate such strains phenotypically.
Nevertheless, molecular biology is a powerful tool for
diagnosis. We used a 16S rRNA gene sequencing as a
global approach for strains that were not C. jejuni, C. coli,
or C. fetus. We confirmed that the intraspecies variability
of A. butzleri 16S rRNA gene sequences is low (0.4%),
lower than that found for C. coli (1.5%) or C. lari (2.5%)
(15), and that interspecies variability is high. This
approach, which is expensive and difficult to implement, is
not accessible to a routine laboratory, but simple phenotyp-
ic tests can be applied to detect these microorganisms. The
combination of phenotypic tests and selective agar medi-
um will determine the real incidence of A. butzleri infec-
tion, which will add evidence that A. butzleri is an
etiologic agent of diarrhea. A determination of the preva-
lence of A. butzleri in normal stool will also help establish
the prevalence of this organism in diarrheal stool.
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